Dr. Gourlay, an assistant professor in the UNC School of Medicine and an adjunct assistant professor in the UNC Gillings School of Global Public Health, is honored for a study that helped define appropriate bone density screening intervals for women ages 65 and older.
The review summarizes the results of a systematic review of clinical interventions for adults exposed to at least one traumatic event such as war, a natural or manmade disaster, motor vehicle accidents, community violence, sexual assault or domestic violence.
On Monday, April 1, the Johnston Health Board of Commissioners announced that it is entering into exclusive negotiations for a partnership with UNC Health Care.
The study is the first published population-based examination of racial disparities in prostate cancer treatment delay.
A study led by UNC researchers indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis.
A team led by Dr. Stanley Lemon discovered that hepatitis A virus does not have an envelope when found in the environment, but acquires one from the cells that it grows in within the liver. It circulates in the blood completely cloaked in these membranes.
The accomplishment provides a much-needed resource for scientists eager to uncover the true mechanisms of human stem cell biology. It also enables them to explore new tactics to treat inflammatory bowel disease or to ameliorate the side effects of chemotherapy and radiation, which often damage the gut.
This discovery has implications for how people perceive hot and cold temperatures and for why people with certain forms of chronic pain experience heightened responses to cold temperatures.
By better understanding the molecular and biological mechanisms involved with schizophrenia, scientists hope to use this new genetic information to one day develop and design drugs that are more efficacious and have fewer side effects.
In the first application of this approach, the UNC researchers showed how a protein called Src kinase influences the way cells extend and move, a previously unknown role that is consistent with the protein’s ties to tumor progression and metastasis.
Experts from 80 countries cite time-limited opportunity, endorse comprehensive new Polio eradication strategy
Polio eradication is achievable and urgent, declare 400+ global scientists, doctors and experts including UNC Health Care's Dr. William L. Roper.
UNC's Dr. Adam Goldstein and colleagues discuss in the New England Journal of Medicine medical, ethical, and legal concerns about physician involvement in concealed weapons permits. They argue that standards, protocols and new policies are needed for physicians to adequately assess a patient’s physical or mental competency in concealed-weapons permitting.
Researchers at the University of North Carolina have discovered that transcription factors regulating the levels of oxygen in the blood also play a role in the spread of the skin cancer melanoma.
A new study by UNC researchers finds that patients who suffer a STEMI heart attack while hospitalized are 10 times more likely to die than patients who suffer a STEMI outside the hospital.
Joseph M. Stavas, MD, a professor of Radiology at the UNC School of Medicine, ran the Boston Marathon with his daughter, Natalie. Both were at mile marker 26 when the bombings occurred. Watch this video from the Boston Globe to see how the father-daughter team helped victims of the attack in the immediate aftermath.
The antibody, created at the University of North Carolina, is the first therapeutic discovered that targets a protein known as SFRP2.
We interrupt your regular programming of real doctors, real people and RN: Real Nurses this month to bring you a special combined edition. We're calling it the Spartan Edition!
This agreement replaces the current management agreement between Pardee and UNC Health Care and extends the relationship from 10 to 25 years.
The research, led jointly by the University of North Carolina School of Medicine and the University of Florida, suggests that the safety and efficacy of the antiviral drugs telaprevir and boceprevir are similar for patients taking the treatments in real-world settings to what was observed in clinical trials.